Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Willgrow is an ambitious investment firm originating from a first-generation family office in the Baltics. The principals have significant entrepreneurial experience, notably founding and running a successful multi-billion logistics business. Willgrow actively invests in private equity, venture capital, credit funds, real assets, and direct investments globally. Its operating businesses include GIRTEKA (logistics/transport) and SIRIN (industrial real estate/development). There is no evidence that Willgrow operates as or invests specifically in life sciences or healthcare sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Willgrow.